Announcements

MoonLake Immunotherapeutics filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting a net loss of $131.5 million for the first half of the year and a significant increase in cash holdings compared to …

MoonLake Immunotherapeutics filed a Current Report on Form 8-K on August 10, 2026, disclosing its financial results for the quarter ended June 30, 2026, and announcing positive topline week 16 results from its Phase 3 IZAR-1 trial of sonelokimab in psoriatic arthritis.

Apogee Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing financial results, a pending merger with a wholly owned subsidiary of AbbVie Inc., and updated risk factors.

Conduent Incorporated filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission on August 10, 2026, furnishing its second quarter 2026 financial results press release and an accompanying investor presentation used during a financial results call held the same day.

International Seaways, Inc. filed a Form 8-K with the SEC on August 10, 2026, disclosing a quarterly dividend declaration and the release of its second quarter 2026 earnings.

International Seaways, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting net income of $294,925 thousand for the second quarter and $581,068 thousand for the first half of the year.

N-able, Inc. filed a Form 10-K/A on August 10, 2026, amending its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, to disclose a material weakness in internal control over financial reporting and to revise previously issued financial statements for …